Floatz logo

Therapeutic Asset Ratings

368 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cdx-585
Pancreatic Neoplasm
Celldex TherapeuticsP1C (39)
Cue-102
Pancreatic Neoplasm
Cue BiopharmaP1C (39)
Ezabenlimab
Pancreatic Neoplasm
Boehringer IngelheimP1C (39)
nmk89
Pancreatic Neoplasm
Nihon Medi-Physics Co., Ltd.P1C (39)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Pancreatic Neoplasm
Washington University School of MedicineP1C (39)
Sotigalimab
Pancreatic Neoplasm
James Cleary, MD, PhDP1/2C (37)
Nisevokitug
Pancreatic Neoplasm
Kimberly Perez, MDP2C (36)
64Cu-Tz-SarAr
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (36)
agx101
Pancreatic Neoplasm
Angiex, Inc.P1C (36)
Amivantamab-Vmjw
Pancreatic Neoplasm
Fate TherapeuticsP1C (36)
Anti-Egfr-Bispecific Antibody Armed Activated T-Cells
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (36)
AQUOCOBALAMIN
Pancreatic Neoplasm
General Oncology, Inc.P1C (36)
Autogene Cevumeran
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1C (36)
Azirkitug
Pancreatic Neoplasm
AbbVieP1C (36)
Bl-M17D1
Pancreatic Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1C (36)
Bpi-442096
Pancreatic Neoplasm
Betta Pharmaceuticals Co., Ltd.P1C (36)
Brodalumab
Pancreatic Neoplasm
Brian Henick, MDP1C (36)
Car-M-C-Met Cell Intraperitoneal Infusion
Pancreatic Neoplasm
Peking Union Medical College HospitalP1C (36)
CARMUSTINE
Pancreatic Neoplasm
General Oncology, Inc.P1C (36)
CHLORPHENESIN CARBAMATE
Pancreatic Neoplasm
Changhoon YooP1C (36)
Claudin 18.2 Car-T
Pancreatic Neoplasm
Suzhou Immunofoco Biotechnology Co., LtdP1C (36)
Cl-Nk-001
Pancreatic Neoplasm
Changhai HospitalP1C (36)
Cl-Nk-003
Pancreatic Neoplasm
Changhai HospitalP1C (36)
Cobicistat
Pancreatic Neoplasm
German Cancer Research CenterP1C (36)
cpo102
Pancreatic Neoplasm
Conjupro Biotherapeutics, Inc.P1C (36)
Showing 226 to 250 of 368 assets
PreviousPage 10 of 15Next